Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    OmniAb, Inc. (OABIW)

    Price:

    0.22 USD

    ( - 0 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    OABIW
    Name
    OmniAb, Inc.
    Industry
    Biotechnology
    Sector
    Healthcare
    Price
    0.221
    Market Cap
    265.746M
    Enterprise value
    357.938M
    Currency
    USD
    Ceo
    Matthew W. Foehr
    Full Time Employees
    114
    Website
    Ipo Date
    City
    EmeryVille
    Address
    5980 Horton Street

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Regeneron Pharmaceuticals, Inc.

    VALUE SCORE:

    6

    Symbol
    REGN
    Market Cap
    61.406B
    Industry
    Biotechnology
    Sector
    Healthcare

    2nd position

    Genmab A/S

    VALUE SCORE:

    11

    Symbol
    GMAB
    Market Cap
    99.056B
    Industry
    Biotechnology
    Sector
    Healthcare

    The best

    Agios Pharmaceuticals, Inc.

    VALUE SCORE:

    12

    Symbol
    AGIO
    Market Cap
    2.254B
    Industry
    Biotechnology
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -3.092
    P/S
    9.858
    P/B
    0.749
    Debt/Equity
    0.083
    EV/FCF
    8.152
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    10.010
    Earnings yield
    -0.323
    Debt/assets
    0.074
    FUNDAMENTALS
    Net debt/ebidta
    -0.066
    Interest coverage
    0
    Research And Developement To Revenue
    2.175
    Intangile to total assets
    0.729
    Capex to operating cash flow
    0.020
    Capex to revenue
    0.025
    Capex to depreciation
    0.026
    Return on tangible assets
    -0.793
    Debt to market cap
    0.096
    Piotroski Score
    4.000
    FUNDAMENTALS
    PEG
    0.897
    P/CF
    6.807
    P/FCF
    8.028
    RoA %
    -21.482
    RoIC %
    -23.096
    Gross Profit Margin %
    78.673
    Quick Ratio
    3.768
    Current Ratio
    3.768
    Net Profit Margin %
    -275.833
    Net-Net
    0.095
    FUNDAMENTALS PER SHARE
    FCF per share
    0.266
    Revenue per share
    0.217
    Net income per share
    -0.598
    Operating cash flow per share
    0.272
    Free cash flow per share
    0.266
    Cash per share
    0.392
    Book value per share
    2.469
    Tangible book value per share
    0.438
    Shareholders equity per share
    2.469
    Interest debt per share
    0.205
    TECHNICAL
    52 weeks high
    0.259
    52 weeks low
    0.175
    Current trading session High
    0.259
    Current trading session Low
    0.160
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    DESCRIPTION

    OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur that features unique structural attributes of cow antibodies for complex targets. The company was founded in 2012 and is headquartered in Emeryville, California.

    NEWS